Status:
RECRUITING
Prospective Evaluation of the LithoVue Elite Ureteroscope
Lead Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Collaborating Sponsors:
University of British Columbia
Western University, Canada
Conditions:
Kidney Stone
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Flexible ureteroscopy has become the main surgical treatment for kidney stone disease. The procedure uses many types of ureteroscopes (disposable and non-disposable). Currently we are using the LithoV...
Detailed Description
This is a single arm multicenter study looking at real world results of ureteroscopy with the new digital flexible ureteroscope LVE. The study will involve 6 participating institutions. Each site will...
Eligibility Criteria
Inclusion
- Patient scheduled for ureteroscopy and laser lithotripsy
- Non-obstructing renal stone 2 cm total stone diameter (if multiple stones, then sum of maximum diameters) or less undergoing flexible ureteroscopy
- age \> 18 years
Exclusion
- age \< 18 years
- pregnancy status =positive
- indwelling nephrostomy tube
- severe hydronephrosis that in the opinion of the investigator, will make it challenging to make the patient stone free
- renal anomalies
Key Trial Info
Start Date :
January 16 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 15 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04900688
Start Date
January 16 2023
End Date
September 15 2025
Last Update
June 7 2024
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Vancouver General Hospital
Vancouver, British Columbia, Canada, V6X 1Z9
2
Western University
London, Ontario, Canada, N6A 3K7
3
Centre Hospitalier de l'Université de Montréal (CHUM)
Montreal, Quebec, Canada, H2X 3E4
4
Hôpital Maisonneuve-Rosemont (HMR)
Montreal East, Quebec, Canada, H1T2M4